Somanath Kundu: h-index, Total Citations, and Citation Map

Somanath Kundu's h-index is 13 (14 i10-index, 455+ total citations across 26+ publications) according to Google Scholar as of May 2026. Somanath Kundu is affiliated with SUNY Upstate Medical University.

Somanath Kundu is a researcher affiliated with SUNY Upstate Medical University, specializing in Tumor microenvironment, Immunotherapy, ECM proteins. Their work has been cited 455 times. This profile visualizes their global influence, highlighting strong citation networks in China.

Tumor microenvironmentImmunotherapyECM proteins

13h-index

14i10-index

455Citations

26Works

36Countries

SUNY Upstate Medical University•

Google Scholar

Data updated 4 hours ago

Somanath Kundu's Citation Metrics

Bibliometric impact based on 26 indexed publications.

H-Index: 13
i10-Index: 14
Total Citations: 455
Citing Countries: 36

As of May 2026.

Somanath Kundu has an h-index of 13 and 455 total citations across 26 publications, with research cited by institutions in 36 countries.

Crawled 26 / 26 publications·435 / 455 citations

View on Google Scholar →

Download Exports (PNG, CSV, Poster)

Free Viewing Somanath Kundu's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.

Loading citation map and citing papers — this usually takes a few seconds for scholars with many citations.

Global Impact Map

Visualizing the geographic distribution of institutions that have cited your work.

Building your citation map

Starting…

Crawling Google Scholar… this usually takes 1–3 minutes

Pins will appear here as institutions are resolved — no need to refresh.

Top Cited Works

Year:

Tip: clickto hide a row from the map

Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin

201493

No citing papers captured yet.

Top Citing Countries

36 total

China(CN)

United States(US)

India(IN)

Italy(IT)

Poland(PL)

United Kingdom(GB)

Russia(RU)

South Korea(KR)

Portugal(PT)

Hungary(HU)

Iran(IR)

Canada(CA)

Egypt(EG)

Belgium(BE)

Turkey(TR)

Taiwan(TW)

Australia(AU)

Finland(FI)

Japan(JP)

Serbia(RS)

Singapore(SG)

Spain(ES)

Thailand(TH)

Jordan(JO)

Israel(IL)

Ireland(IE)

Saudi Arabia(SA)

Austria(AT)

France(FR)

Slovakia(SK)

South Africa(ZA)

Brazil(BR)

Germany(DE)

Morocco(MA)

Netherlands(NL)

Malaysia(MY)

Top Citing Institutions

20 total

Sort:

Broad Institute of MIT and Harvard

Sri Sathya Sai Institute of Higher Learning

St. Joseph's Hospital and Medical Center

Adam Mickiewicz University in Poznań

Shanghai Jiao Tong University

Tehran University of Medical Sciences

Institute of Biomedical Chemistry

Chinese Academy of Sciences

East China Normal University

Shihezi University

Southeast University

UCLouvain

National Institute of Pharmaceutical Education and Research

Guangzhou University of Chinese Medicine

University of Ferrara

Clemson University

University of Verona

Mashhad University of Medical Sciences

University of Eastern Finland

Vanderbilt University Medical Center

Visa Evidence Package

Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.

Significant Contributions

EB-1A Report · Free EB-1B Report · Free NIW Report · Free

Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.

Citation independence

86.8% independent296 independent6 self39 co-author0 same-institution

52 citing papers could not be classified (no author data) — excluded from the percentages above.

Contribution 1

The researcher pioneered bile acid-based conjugate strategies for targeted breast cancer therapy, establishing a foundational framework for localized drug delivery and exploring broader gastrointestinal cancer mechanisms.

Core paper

Design, synthesis, and mechanistic investigations of bile acid–tamoxifen conjugates for breast cancer therapy

2013 · 65 citations

Follow-up work

Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin

2014 · 93 citations

Follow-up work

Cross‐talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications

2015 · 74 citations

Contribution 2

The researcher pioneered the design and mechanistic analysis of lithocholic acid amphiphiles for colon cancer therapy, establishing a foundational framework for bile acid-based anticancer agents.

Core paper

Synthesis, structure–activity relationship, and mechanistic investigation of lithocholic acid amphiphiles for colon cancer therapy

2015 · 37 citations

Follow-up work

Deciphering the role of hydrophobic and hydrophilic bile acids in angiogenesis using in vitro and in vivo model systems

2017 · 35 citations

Contribution 3

The researcher identified fibulin-3 as a driver of pleural mesothelioma growth via PI3K/Akt signaling and extended this mechanism to glioblastoma immunosuppression.

Core paper

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

2022 · 14 citations

Follow-up work

Inhibition of extracellular matrix protein fibulin-3 reduces immunosuppressive signaling and increases macrophage activation in glioblastoma

2025 · 1 citations

Finding similar USCIS appeal decisions…

Citation trend (last 10 years)Click to expand